Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Lincoln Memorial DeBusk College of Osteopathic Medicine, Lincoln Memorial University, Knoxville, TN 37902, USA.
Viruses. 2024 Jul 24;16(8):1183. doi: 10.3390/v16081183.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease (COVID-19), induced a global pandemic with a diverse array of clinical manifestations. While the acute phase of the pandemic may be waning, the intricacies of COVID-19's impact on neurological health remain a crucial area of investigation. Early recognition of the spectrum of COVID-19 symptoms, ranging from mild fever and cough to life-threatening respiratory distress and multi-organ failure, underscored the significance of neurological complications, including anosmia, seizures, stroke, disorientation, encephalopathy, and paralysis. Notably, patients requiring intensive care unit (ICU) admission due to neurological challenges or due to them exhibiting neurological abnormalities in the ICU have shown increased mortality rates. COVID-19 can lead to a range of neurological complications such as anosmia, stroke, paralysis, cranial nerve deficits, encephalopathy, delirium, meningitis, seizures, etc., in affected patients. This review elucidates the burgeoning landscape of neurological sequelae associated with SARS-CoV-2 infection and explores the underlying neurobiological mechanisms driving these diverse manifestations. A meticulous examination of potential neuroinvasion routes by SARS-CoV-2 underscores the intricate interplay between the virus and the nervous system. Moreover, we dissect the diverse neurological manifestations emphasizing the necessity of a multifaceted approach to understanding the disease's neurological footprint. In addition to elucidating the pathophysiological underpinnings, this review surveys current therapeutic modalities and delineates prospective avenues for neuro-COVID research. By integrating epidemiological, clinical, and diagnostic parameters, we endeavor to foster a comprehensive analysis of the nexus between COVID-19 and neurological health, thereby laying the groundwork for targeted therapeutic interventions and long-term management strategies.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是导致冠状病毒病(COVID-19)的病原体,引发了具有多种临床表现的全球大流行。虽然大流行的急性期可能正在减弱,但 COVID-19 对神经系统健康的影响的复杂性仍然是一个重要的研究领域。早期认识到 COVID-19 的症状范围,从轻度发热和咳嗽到危及生命的呼吸窘迫和多器官衰竭,强调了神经系统并发症的重要性,包括嗅觉丧失、癫痫发作、中风、定向障碍、脑病和瘫痪。值得注意的是,由于神经系统挑战或在 ICU 中表现出神经系统异常而需要入住 ICU 的患者,死亡率较高。COVID-19 可导致受影响患者出现多种神经系统并发症,如嗅觉丧失、中风、瘫痪、颅神经缺陷、脑病、意识障碍、脑膜炎、癫痫发作等。本综述阐明了与 SARS-CoV-2 感染相关的神经系统后遗症的新兴领域,并探讨了驱动这些不同表现的潜在神经生物学机制。对 SARS-CoV-2 通过潜在神经入侵途径的细致检查强调了病毒与神经系统之间的复杂相互作用。此外,我们剖析了不同的神经系统表现,强调了采用多方面方法理解疾病的神经系统特征的必要性。除了解析病理生理学基础外,本综述还调查了当前的治疗方式,并描述了神经 COVID 研究的未来途径。通过整合流行病学、临床和诊断参数,我们努力促进 COVID-19 和神经系统健康之间的关系的全面分析,从而为靶向治疗干预和长期管理策略奠定基础。